Fundrasing

NeoMed Innovation IV closed at EUR 104 million

NeoMed Innovation IV LP closed at EUR 104 million. The investors are fund-of-funds, institutional and private investors situated in Europe and Saudi Arabia.

NeoMed is one of Europe’s leading venture capital firms which specialises in healthcare and life sciences. It invests in innovative and emerging companies, primarily in Continental Europe and Scandinavia.

The new fund recently made its first investment in the Swiss company Endosense SA.

Read more


Date of Transaction2005-12-30
Closing Final
FundNeomed Innovation Fund IV
ManagerNeomed Management
StageVenture
LocationNorway, USA, RoW
Ind. FocusLife Science
Fund SizeEUR 103.6m
Vintage Year2005
 

More news Neomed Innovation Fund IV

More fundraisings

 
 
Location
Stage
Industry
 
 

Ownership

 
18.3%
Neomed Innovation Fund IV
 
 
 

Latest PE Voice

- Communication is essential

- 9/1/2010 3:02:00 PM
Aarbakke Group CEO, Inge Brigt Aarbakke, shares his views about private equity financing
 
 

Calendar

2010-09-08 in Zurich

European Energy Venture Fair

2010-09-23 in Stockholm

The Argentum Private Equity Conference

2010-09-24 in Stockholm

The Argentum Symposium 2010

2010-09-30 in Oslo

NVCA Høsttreff 2010

2010-10-06 in Aberdeen

Oiltech Entrepreneur's Advisory Workshop
 
Copyright Argentum 2009